Sub navigation menu:
Mirae Asset Horizons China Biotech ETF
The Sub-Fund is newly set-up and has been launched for less than one calendar year. As such, there is insufficient data to provide a useful indication of past performance to investors
Returns
-
|
1Mo |
3Mo |
6Mo |
1Yr |
YTD |
Since Inception |
Source: Mirae Asset Global Investments (Hong Kong) Limited.
|
Mirae Asset Horizons China Biotech ETF |
|
|
|
|
|
|
Benchmark - Solactive China Biotech Index |
|
|
|
|
|
|
Past Performance
-
|
- |
- |
- |
- |
- |
Source: Mirae Asset Global Investments (Hong Kong) Limited.
• Past performance information is not indicative of future performance. Investors may not get back the full amount invested.
• The computation basis of the performance is based on the calendar year end, NAV-to-NAV.
• These figures show by how much the Sub-Fund increased or decreased in value during the calendar year shown.
• Performance data has been calculated in RMB including ongoing charges and excluding trading costs on SEHK you might have to pay.
• Where no past performance is shown there was insufficient data available in that year to provide performance.
• The Fund launch date : 24 July 2019
|
Mirae Asset Horizons China Biotech ETF |
- |
- |
- |
- |
- |
Benchmark - Solactive China Biotech Index |
- |
- |
- |
- |
- |